Nuvo Pharmaceuticals Inc NRIFF

RE: Why Delay

[HippygirL74]

Very good post Henrick Muller.  That's exactly how i interpret the situation.  Hippy. 

Your post:

The additional info that Nuvo presented to FDA was as per Covidien's request.  The info was crucial from the sales standpoint as it would change the labelling in such a way that there would not be "warnings" of any sort needed to be placed on the label and/or monograph.
The delay also did not affect anything short term for Covidien as they are planning to start the sales in 2010. However, with a better label and a revised monograph based on the 2-yr tox tests, the sales should be better in the long run.

As always with FDA, no news is good news.  So, if there is no announcement pre-market tomorrow, expect an approval coming within the next few days.

Also, as per the House positions gains during the last few trading days; House 84 and 88 are making a lot of money (which is consistent with the idea that they were involved in MM manipulations).

Henry

Ps. always do your own research.